These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1894308)

  • 1. A cluster of mutations in HLA-A2 alpha 2 helix abolishes peptide recognition by T cells.
    Moots RJ; Matsui M; Pazmany L; McMichael AJ; Frelinger JA
    Immunogenetics; 1991; 34(3):141-8. PubMed ID: 1894308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide.
    Hogan KT; Shimojo N; Walk SF; Engelhard VH; Maloy WL; Coligan JE; Biddison WE
    J Exp Med; 1988 Aug; 168(2):725-36. PubMed ID: 3261776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of the six peptide-binding pockets of HLA-A2.1 in influenza A matrix peptide-specific cytotoxic T-lymphocyte reactivity.
    Matsui M; Moots RJ; McMichael AJ; Frelinger JA
    Hum Immunol; 1994 Oct; 41(2):160-6. PubMed ID: 7860362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition.
    Matsui M; Moots RJ; Warburton RJ; Peace-Brewer AL; Tussey LG; Quinn DG; McMichael AJ; Frelinger JA
    J Immunol; 1995 Feb; 154(3):1088-96. PubMed ID: 7822785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of mutations and variations of HLA-A2 on recognition of a virus peptide epitope by cytotoxic T lymphocytes.
    McMichael AJ; Gotch FM; Santos-Aguado J; Strominger JL
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9194-8. PubMed ID: 2461564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of amino acid substitutions in the beta-sheet floor and alpha-2 helix of HLA-A2 on recognition by alloreactive viral peptide-specific cytotoxic T lymphocytes.
    Mattson DH; Shimojo N; Cowan EP; Baskin JJ; Turner RV; Shvetsky BD; Coligan JE; Maloy WL; Biddison WE
    J Immunol; 1989 Aug; 143(4):1101-7. PubMed ID: 2473117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 45 pocket of HLA-A2.1 plays a role in presentation of influenza virus matrix peptide and alloantigens.
    Winter CC; Carreno BM; Turner RV; Koenig S; Biddison WE
    J Immunol; 1991 May; 146(10):3508-12. PubMed ID: 2026879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residues outside of the HLA-A2 peptide-binding groove can abrogate or enhance recognition of influenza virus matrix peptide pulsed cells by cytotoxic T lymphocytes.
    Teng JM; Hogan KT
    Mol Immunol; 1994 Apr; 31(6):445-57. PubMed ID: 8183283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single amino acid substitution in HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55-73.
    Shimojo N; Cowan EP; Engelhard VH; Maloy WL; Coligan JE; Biddison WE
    J Immunol; 1989 Jul; 143(2):558-64. PubMed ID: 2472444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definition of a human T cell epitope from influenza A non-structural protein 1 using HLA-A2.1 transgenic mice.
    Man S; Newberg MH; Crotzer VL; Luckey CJ; Williams NS; Chen Y; Huczko EL; Ridge JP; Engelhard VH
    Int Immunol; 1995 Apr; 7(4):597-605. PubMed ID: 7547687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both major and minor peptide-binding pockets in HLA-A2 influence the presentation of influenza virus matrix peptide to cytotoxic T lymphocytes.
    Teng JM; Hogan KT
    Mol Immunol; 1994 Apr; 31(6):459-70. PubMed ID: 8183284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2.
    Robbins PA; Lettice LA; Rota P; Santos-Aguado J; Rothbard J; McMichael AJ; Strominger JL
    J Immunol; 1989 Dec; 143(12):4098-103. PubMed ID: 2480387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2-specific antibodies and cytotoxic T lymphocytes.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1989 Mar; 142(6):2097-104. PubMed ID: 2466083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza A-specific, HLA-A2.1-restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein.
    Engelhard VH; Lacy E; Ridge JP
    J Immunol; 1991 Feb; 146(4):1226-32. PubMed ID: 1704033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1988 Oct; 141(7):2519-25. PubMed ID: 2459215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes.
    Morrison J; Elvin J; Latron F; Gotch F; Moots R; Strominger JL; McMichael A
    Eur J Immunol; 1992 Apr; 22(4):903-7. PubMed ID: 1372560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
    Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
    Maeurer MJ; Chan HW; Karbach J; Salter RD; Knuth A; Lotze MT; Storkus WJ
    Eur J Immunol; 1996 Nov; 26(11):2613-23. PubMed ID: 8921947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positioning of a peptide in the cleft of HLA-A2 by complementing amino acid changes.
    Latron F; Moots R; Rothbard JB; Garrett TP; Strominger JL; McMichael A
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11325-9. PubMed ID: 1763045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma.
    Brändle D; Brasseur F; Weynants P; Boon T; Van den Eynde B
    J Exp Med; 1996 Jun; 183(6):2501-8. PubMed ID: 8676070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.